CXCL8 and gastric cancer: We further treated gastric cancer cells with IL‐8 (10 ng/ml) in the presence of 17β‐estradiol (E2; 10−8 M) for 3 hrs, and measured the phosphorylation/activation of cancer progression‐related proteins by immunoblotting assay.